Network pharmacology analysis identified the top ten target genes for THSWD treatment of delirium, including MAOA, MAOB, SNCA, IL1B, APP, PTGS2, TNF, IL6, GSK3B and ABHE. The gene discussed is MAOB; the disease is delirium.